Skip to main content
. 2014 Nov;74(11):995–1002. doi: 10.1055/s-0034-1383297

Fig. 2.

Fig. 2

 Changes in HDL-C levels (HDL-C: lipoproteins with high density cholesterol) after estrogen monotherapy, estrogen and progesterone administration, cyclical administration of estrogen with MPA (medroxyprogesterone acetate), continuous administration of estrogen with MPA, and placebo (from the PEPI trial) 64. CEE: conjugated equine estrogen.